作者:Yogesh B. Surase、Kirandeep Samby、Sagar R. Amale、Ruchi Sood、Kedar P. Purnapatre、Pawan K. Pareek、Biswajit Das、Kamna Nanda、Subodh Kumar、Ashwani K. Verma
DOI:10.1016/j.bmcl.2017.05.081
日期:2017.8
5-a]pyrazin-4-one was identified by screening of diverse set of compounds against M. smegmatis ATP synthase. Herein, we disclose our efforts to develop the structure activity relationship against Mycobacterium tuberculosis (Mtb.H37Rv strain) around the identified hit 1. A scaffold hopping approach was used to identify compounds 14a, 14b and 24a with improved activity against MTb.H37Rv.
通过筛选针对耻垢分枝杆菌ATP合酶的多种化合物,确定了非二芳基喹啉骨架6,7-二氢吡唑并[1,5-a]吡嗪-4-酮。在此,我们披露我们努力开发针对构效关系结核分枝杆菌(结核杆菌。分枝杆菌菌株)围绕确定的命中1。使用支架跳跃法鉴定对MTb.H37Rv具有改善的活性的化合物14a,14b和24a。